Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 4Phase 3 3Phase 1 3Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Osteoporosis 1Neuralgia 1Neoplasms 1Hematologic Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Geritol × Clear all
NCT00824993 2018-09-13

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

M.D. Anderson Cancer Center

Phase 3 Completed
78 enrolled 7 charts
Other hematologic neoplasm

Bone Diseases, Metabolic, Osteoporosis, Hematologic Neoplasms

NCT00003623 2016-07-13

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
21 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00659269 2016-02-26

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

New Mexico Cancer Research Alliance

Phase 3 Completed
319 enrolled 7 charts

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡